Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amount of nutrients such as vitamins, proteins, and minerals. The clinical nutrition products are specially formulated to nourish and improve the quality of life for people of all ages, which is, in turn, favoring the growth of clinical nutrition market. Oral administration of clinical nutrition products is not viable in patients with severe infection or burns and those recovering from major surgery or acute trauma. Nutritional need in such patients can be met by specialized nutritional feeding known as enteral or parenteral feeding. The enteral nutrition is a segment of clinical nutrition, which includes liquid formula diets and it is administered by feeding tubes into the gastro intestinal tract. Whereas, parenteral feeding is the clinical nutrition administered by the intravascular route.

The Canada clinical nutrition market is estimated to be valued at US$ 593.0 million in 2021 and is expected to exhibit a CAGR of 4.9% over the forecast period (2021-2028).

Figure 1. Canada Clinical Nutrition Market Value (US$ Mn), by Nutrition Type, 2021

Canada Clinical Nutrition  | Coherent Market Insights

Rising prevalence of chronic diseases is expected to favor the growth of Canada clinical nutrition market

The increasing prevalence of chronic diseases such as diabetes and chronic kidney disease is resulting in increased risk of malnutrition, which is expected to drive the Canada clinical nutrition market growth. Clinical nutrition plays a crucial role in reducing complications associated with certain chronic conditions such as type 2 diabetes and chronic kidney disease (CKD).

According to the article published in the Canadian Journal of Diabetes in 2018, the estimated prevalence of diabetes in Canada was 3.4 million or 9.3% of the population, and is predicted to rise to five million or 12.1% of the population by 2025, representing 44% increase from 2015 to 2025.

According to the report published by Kidney Foundation in March 2020, 1 in 10 people suffer from kidney disease in Canada which totals to 4 million people and more than 50,000 Canadians were treated for kidney failure.

request-sample

Canada Clinical Nutrition Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 593.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2022 to 2028 CAGR: 4.9% 2028 Value Projection: US$ 828.5 Mn
Geographies covered:
  • Canada
Segments covered:
  • By Nutrition Type:
    • Enteral Nutrition: Standard Nutrition, Disease Specific Nutrition
    • Parenteral Nutrition: Amino Acid, Carbohydrates, Vitamins and Minerals, Others
  • By Form: Powder, Liquid, Others
  • By Age Group: Infant Nutrition, Adult Nutrition, Geriatric Nutrition
  • By Application: Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other Applications
  • By End User: Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities
Companies covered:

Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, NESTLÉ S.A., DANONE S.A., B.Braun Melsungen AG, Mead Johnson & Company, LLC, Perrigo Company PLC, Koru Nutrition Inc., and Koninklijke DSM N.V.

Growth Drivers:
  • Rising prevalence of chronic diseases
  • Increasing number of product launches
Restraints & Challenges:
  • Side effects due to excessive consumption of clinical nutrition products

Figure 2. Canada Clinical Nutrition Market Share (%), by Age Group, (2021-2028)

Canada Clinical Nutrition  | Coherent Market Insights

Increasing number of product launches is expected to drive the segment growth over the forecast period.

Various manufacturers are engaged in development and launches of innovative and novel clinical nutrition products, which are expected to drive the growth of the Canada clinical nutrition market.

In November 2020, Abbott Laboratories, launched its most innovative infant formula, Similac Pro-Advance with 2'-Fucosyllactose Oligosaccharide† (2'-FL†), which is the first product in Canada with this breakthrough ingredient in infant formula.

In September 2018, Baxter Canada, a subsidiary of Baxter International received Health Canada approval for OLIMEL 7.6% and OLIMEL 7.6% E (amino acids, dextrose, lipids with/without electrolytes, injectable emulsion), which is indicated for parenteral nutrition for adults, when oral or enteral nutrition is impossible, insufficient, or contraindicated.

Canada Clinical Nutrition Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdown in Canada have impacted the financial situation of several business sectors. Private healthcare is one of the sectors, which is majorly impacted by the COVID-19 pandemic. Moreover, coronavirus pandemic has negatively impacted the development, production, and supply of nutritional products and affected growth of the nutrition and healthcare businesses of various clinical nutrition companies. The COVID-19 pandemic has restricted access to healthcare facilities and community services. Consequently, this is increasing the risk of individuals developing malnutrition. Hence, in such critical times, nutrition plays an essential role in building immunity. Though the demand for clinical nutrients is high, the restriction imposed has hampered the supply to a certain extent.

Thus, COVID-19 pandemic has affected the economy in three main ways: 1) By directly affecting the production and demand; 2) By creating disruptions in distribution channels; and 3) By its financial impact on firms and financial markets.

The decreased access to nutrition care services and healthcare professionals owing to limited in-person contact and service cancellations was among the most common challenge that Canadian dietitians reported for discharged patients. However, the pandemic brought a drastic shift in healthcare practices such as the healthcare professionals started taking appointments over call or other virtual services thus, improving the market scenario.

Canada Clinical Nutrition Market - Restraint

The major factors restraining growth of the Canada clinical nutrition market include side effects and complications caused by excessive consumption of products indicated for clinical nutrition. Excess consumption of any nutritional product can lead to life threating conditions. For instance, parenteral nutritional therapy can lead to serious and life threating conditions such as liver dysfunction.

According to a study published in the Annals of Internal Medicine journal, in December 2013, vitamin use was more among elderly Americans, almost 50% of individuals consumed vitamins between the 50 to 64 age group. According to the report, excessive vitamins do not provide health benefits and may even cause harm such as increased urination and uneven heart rate. Furthermore, most supplements do not prevent chronic disease or death.

Key Players

Major players operating in the Canada clinical nutrition market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, NESTLÉ S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company, LLC, Perrigo Company PLC, Koru Nutrition Inc., and Koninklijke DSM N.V.

Clinical nutrition is concerned with the diagnosis and treatment of diseases that affect the intake, absorption, and metabolism of dietary constituents. Clinical nutrition also promotes the health issues by preventing diet-related diseases. As the nutrition plays an important role in the human body, deficiency of essential nutrients could lead to various problems, such as anemia, diabetes, and blood disorder. Clinical nutrition products help to improve metabolism, digestion, absorption, and storage of important micro and micro nutrients in the human body. Clinical nutrition is a huge domain and is mainly classified into infant, enteral, and parental feeding. Infant nutrition includes products for premature babies with special clinical nutrition. The major driving factors for the growth of clinical nutrition market include increasing prevalence of malnutrition, acute trauma, burns, and eating disorder or major surgery.

Market Dynamics

Increasing incidence of chronic diseases, increasing novel product launch and approvals, and increasing adoption of inorganic growth strategies such as acquisition, collaboration, and partnership by key players operating in the market is anticipated to drive the growth of Canada clinical nutrition market over the forecast period. In January 2020, Microsoft and Danone S.A. entered into a collaboration for expanding applications of artificial intelligence in clinical nutrition industry.

In February 2018, Danone S.A. entered into a new phase of its strategic partnership with Yakult Honsha Co, Ltd., a global leader in probiotic beverages, for strengthening their long-term strategic collaboration in probiotics.

In February 2017, Mead Johnson & Company, LLC announced its merger with Reckitt Benckiser Group plc (RB). Mead Johnson will become a new division of RB with its globally-recognized Enfamil and Nutramigen brands joining RB's portfolio of leading consumer health brands.

Key features of the study:

  • This report provides in-depth analysis of the Canada clinical nutrition market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global clinical nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, NESTLÉ S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company, LLC, Perrigo Company PLC, Koru Nutrition Inc., and Koninklijke DSM N.V.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Canada clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Canada clinical nutrition market

Detailed Segmentation:

  • Canada Clinical Nutrition Market, By Nutrition Type:
    • Enteral Nutrition
      • Standard Nutrition
      • Disease Specific Nutrition
    • Parenteral Nutrition
      • Amino Acid
      • Carbohydrates
      • Vitamins and Minerals
      • Others
  • Canada Clinical Nutrition Market, By Form:
    • Powder
    • Liquid
    • Others
  • Canada Clinical Nutrition Market, By Age Group:
    • Infant Nutrition
    • Adult Nutrition
    • Geriatric Nutrition
  • Canada Clinical Nutrition Market, By Application:
    • Diabetes
    • Cancer
    • Critical Care
    • Neurological Disorder
    • Metabolic Syndrome
    • Gastrointestinal Diseases
    • Other Applications
  • Canada Clinical Nutrition Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Long Term Care Facilities
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Baxter International Inc.
    • Fresenius Kabi AG
    • NESTLÉ S.A.
    • DANONE S.A.
    • Braun Melsungen AG
    • Mead Johnson & Company, LLC
    • Perrigo Company PLC
    • Koru Nutrition Inc.
    • Koninklijke DSM N.V.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Nutrition Type
      • Market Snippet, By Form
      • Market Snippet, By Age Group
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Development
    • Top brands for Elderly Patients
    • Market Trends
    • Epidemiology
    • Regulatory Scenario
    • PEST Analysis
    • Global Clinical Nutrition Market Overview
    • Canada Annual sales For Clinical Nutrition Products, 2017-2028
  4. Canada Clinical Nutrition Market - Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Research and Development
    • COVID -19 Epidemiology
  5. Canada Clinical Nutrition Market, By Nutrition Type, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Enteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Standard Nutrition
        • Disease Specific Nutrition
    • Parenteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Amino Acid
        • Carbohydrates
        • Vitamins and Minerals
        • Others
  6. Canada Clinical Nutrition Market, By Form, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  7. Canada Clinical Nutrition Market, By Age Group, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Infant Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Adult Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Geriatric Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  8. Canada Clinical Nutrition Market, By Application, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Critical Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Neurological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Metabolic Syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Gastrointestinal Diseases 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Other Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  9. Canada Clinical Nutrition Market, By End User, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Long Term Care Facilities
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Abbott Laboratories *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NESTLÉ S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DANONE S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mead Johnson & Company, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Perrigo Company PLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Koru Nutrition Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Koninklijke DSM N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 16 market data tables and 31 figures on "Clinical Nutrition Market” -Canada forecast to 2028.

FAQgrowicon

Frequently Asked Questions

The Canada clinical nutrition market size is estimated to be valued at US$ 593.0 million in 2021 and is expected to exhibit a CAGR of 4.9% between 2021 and 2028.
Factors such as the rising prevalence of chronic diseases and increasing product launches are expected to drive the market growth during the forecast period.
Enteral nutrition is the leading nutrition type segment in the market.
Diabetes is the leading application segment in the market.
Major factors hampering growth of the market include side effects and complications caused by excessive consumption of products indicated for clinical nutrition.
Major players operating in the market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, NESTLÉ S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company, LLC, Perrigo Company PLC, Koru Nutrition Inc., and Koninklijke DSM N.V.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.